NEW YORK (Reuters Health) – Older hypertensive patients taking renin-angiotensin drugs that cross the blood-brain barrier (BBB) show slightly less memory decline over time than do those taking non-penetrant...
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok